X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gadodiamide (424) 424
humans (408) 408
radiology, nuclear medicine & medical imaging (367) 367
gadolinium (313) 313
index medicus (302) 302
male (246) 246
magnetic resonance imaging (240) 240
female (230) 230
nephrogenic systemic fibrosis (224) 224
contrast media (185) 185
contrast media - adverse effects (177) 177
middle aged (177) 177
gadodiamide injection (170) 170
adult (153) 153
contrast agents (140) 140
aged (138) 138
dermopathy (132) 132
gadolinium - adverse effects (126) 126
magnetic resonance imaging - methods (121) 121
gadopentetate dimeglumine (117) 117
animals (116) 116
contrast media - administration & dosage (102) 102
dentate nucleus (89) 89
risk factors (88) 88
safety (84) 84
mri (82) 82
fibrosis (81) 81
contrast media - pharmacokinetics (77) 77
nephrogenic fibrosing dermopathy - chemically induced (77) 77
retrospective studies (73) 73
globus-pallidus (72) 72
gadolinium dtpa (69) 69
rats (69) 69
brain (65) 65
gadolinium dtpa - adverse effects (63) 63
medicine & public health (62) 62
abridged index medicus (57) 57
aged, 80 and over (53) 53
adolescent (52) 52
gadolinium dtpa - administration & dosage (51) 51
gd-dtpa (51) 51
gadobenate dimeglumine (50) 50
organometallic compounds - administration & dosage (50) 50
dialysis (49) 49
angiography (48) 48
agents (47) 47
organometallic compounds - adverse effects (44) 44
disease (43) 43
stability (43) 43
gadoteridol (42) 42
urology & nephrology (42) 42
contrast agent (41) 41
dose-response relationship, drug (41) 41
injections, intravenous (41) 41
meglumine - analogs & derivatives (41) 41
contrast media - chemistry (40) 40
deposition (39) 39
gadolinium - administration & dosage (37) 37
kontrastmittel (37) 37
organometallic compounds - pharmacokinetics (37) 37
retention (37) 37
tissue (37) 37
gadolinium - pharmacokinetics (36) 36
gadolinium dtpa - pharmacokinetics (36) 36
image enhancement - methods (36) 36
magnetic resonance imaging - adverse effects (36) 36
media (36) 36
clinical neurology (35) 35
contrast media - pharmacology (35) 35
kernspintomographie (35) 35
radiology (35) 35
renal-failure (35) 35
sensitivity and specificity (35) 35
gadobutrol (34) 34
imaging / radiology (34) 34
neuroradiology (34) 34
gadolinium-dtpa (33) 33
pharmacokinetics (33) 33
skin diseases - chemically induced (32) 32
ultrasound (32) 32
gadolinium - chemistry (31) 31
neuroimaging (31) 31
reproducibility of results (31) 31
skin (31) 31
young adult (31) 31
central-nervous-system (30) 30
images (30) 30
nephrogenic fibrosing dermopathy - epidemiology (30) 30
renal-insufficiency (30) 30
toxicity (30) 30
child (29) 29
gadolinium-based contrast agents (29) 29
risk assessment (29) 29
exposure (28) 28
incidence (27) 27
interventional radiology (27) 27
involvement (27) 27
contrast media - toxicity (26) 26
dimeglumine (26) 26
failure (26) 26
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (627) 627
German (16) 16
French (13) 13
Spanish (3) 3
Czech (1) 1
Italian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Investigative Radiology, ISSN 0020-9996, 2017, Volume 52, Issue 7, pp. 396 - 404
Journal Article
Journal Article
Carbohydrate Polymers, ISSN 0144-8617, 01/2019, Volume 203, pp. 256 - 264
Magnetic resonance imaging (MRI) has been one of the most frequently-used diagnostic tools with high dimensional precision and positioning accuracy in clinical... 
Gadodiamide | Self assembly | Magnetic resonance imaging | T1 relaxivity | Amphiphilic gadodiamide-conjugated chitosan | relaxivity | T-1 relaxivity | POLYMER SCIENCE | METAANALYSIS | EFFICACY | TUMOR | CHEMISTRY, ORGANIC | GADOLINIUM MRI | IMAGES | CANCER-DIAGNOSIS | AGENTS | CHEMISTRY, APPLIED | NEPHROGENIC SYSTEMIC FIBROSIS | Usage | Diagnostic imaging
Journal Article
Magnetic Resonance Imaging, ISSN 0730-725X, 05/2019, Volume 58, pp. 174 - 178
The molecular structure, charge, thermodynamic and kinetic stability are approximately the same for gadodiamide and gadoversetamide, the main substantive... 
Contrast agents | Gadolinium | Safety | Nephrogenic Systemic Fibrosis | OMNISCAN GADODIAMIDE | GADOPENTETATE DIMEGLUMINE | GADODIAMIDE INJECTION | STABILITY | CT ANGIOGRAPHY | GADOVERSETAMIDE | PHARMACOKINETICS | GADOBENATE DIMEGLUMINE | CENTRAL-NERVOUS-SYSTEM | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Thermodynamics | Analysis | Fibrosis
Journal Article
Clinical Radiology, ISSN 0009-9260, 03/2018, Volume 73, Issue 3, pp. 290 - 295
To determine whether repeated gadolinium-based contrast agent administration (GBCA) in children is associated with the development of increased T1-weighted... 
GLOBUS-PALLIDUS | GADODIAMIDE | IMAGES | HIGH SIGNAL INTENSITY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal Article
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 09/2006, Volume 17, Issue 9, pp. 2359 - 2362
Journal Article
Radiology, ISSN 0033-8419, 06/2018, Volume 287, Issue 3, pp. 816 - 823
Purpose: To determine if the increased dentate nucleus signal intensity following six or more doses of a linear gadolinium-based contrast agent (GBCA)... 
HYPERINTENSITY | CONTRAST AGENTS | DEPOSITION | STABILITY | GLOBUS-PALLIDUS | ADMINISTRATIONS | GADODIAMIDE | HEALTHY RATS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | GADOLINIUM RETENTION | BRAIN
Journal Article
Neuro-Oncology, ISSN 1522-8517, 09/2015, Volume 17, Issue 9, pp. 1188 - 1198
Journal Article